72087-39-9 Usage
Uses
Used in Athletic Performance Enhancement:
L-Ornithine (3-methyl-2-oxopentanoate) is used as a performance enhancer for its potential to improve athletic performance by supporting the body's nitrogen balance and aiding in the recovery process.
Used in Wound Healing:
In the medical field, L-Ornithine (3-methyl-2-oxopentanoate) is used as a wound healing agent due to its role in promoting the healing process and supporting tissue repair.
Used in Liver Function Support:
L-Ornithine (3-methyl-2-oxopentanoate) is utilized as a liver function support agent, as it may help in maintaining liver health and supporting its detoxification processes.
Used in Dietary Supplements:
L-Ornithine (3-methyl-2-oxopentanoate) is used as a dietary supplement for individuals seeking to increase their intake of this amino acid, particularly for those who may not get enough through their diet alone.
Used in Food and Beverage Industry:
In the food and beverage industry, L-Ornithine (3-methyl-2-oxopentanoate) is used as a nutritional additive to enhance the amino acid profile of certain products, contributing to their overall nutritional value.
Check Digit Verification of cas no
The CAS Registry Mumber 72087-39-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,0,8 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 72087-39:
(7*7)+(6*2)+(5*0)+(4*8)+(3*7)+(2*3)+(1*9)=129
129 % 10 = 9
So 72087-39-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H10O3.C5H12N2O2/c1-3-4(2)5(7)6(8)9;6-3-1-2-4(7)5(8)9/h4H,3H2,1-2H3,(H,8,9);4H,1-3,6-7H2,(H,8,9)/t;4-/m.0/s1
72087-39-9Relevant academic research and scientific papers
Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
-
, (2008/06/13)
Novel compounds are prepared by reacting ornithine or arginine with alpha keto analogs of branched chain essential amino acids, namely valine, leucine and isoleucine. The compounds are useful either individually or as a mixture in the treatment of hepatic disorders which are characterized by hyperammonemia and portal systemic encephalopathy. Use of these compounds in treatment of renal failure also appears promising.
